EMEA-002644-PIP01-19-M01 - paediatric investigation plan

Cyclophosphamide

Key facts

• Active Substance:
  Cyclophosphamide
• Therapeutic area:
  Oncology
• Decision number:
  P/0490/2021
• PIP number:
  EMEA-002644-PIP01-19-M01
• Pharmaceutical form(s):
  Powder for oral solution
• Condition(s) / indication(s):
  Treatment of all malignant neoplasms
• Route(s) of administration:
  • Oral use
  • Gastric use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  03/12/2021

Decision

P/0490/2021 : EMA decision of 3 December 2021 on the acceptance of a modification of an agreed paediatric investigation plan for cyclophosphamide (Zenew and associated names), (EMEA-002644-PIP01-19-M01)

AdoptedReference Number: EMA/627032/2021